[Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002908:Chronic Disease; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D011725:Pyridines; D014665:Vasodilator Agents
Ulteriore sperimentazione di un vasodilatatore ad azione protratta su 397 pazienti portatori di arteriopatia obliterante cronica periferica su base sclerotica.